• Citer

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck

par Machiels, Jean Pascal;Skartved, Niels Jörgen Østergaard N.J.;Horak, Ivan I.D.;Pamperin, P.;Braun, Stephanie ;Gauler, Thomas Christoph;Specenier, Pol M;Krauß, Jürgen;Dietz, Andreas;Kaminsky, Marie Christine;Lalami, Yassine ;Henket, Monique;Keilholz, Ulrich;Knecht, Rainald
Référence Cancer chemotherapy and pharmacology, 76, 1, page (13-20)
Publication Publié, 2015-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
Auteur:	Machiels, Jean Pascal; Skartved, Niels Jörgen Østergaard N.J.; Horak, Ivan I.D.; Pamperin, P.; Braun, Stephanie; Gauler, Thomas Christoph; Specenier, Pol M; Krauß, Jürgen; Dietz, Andreas; Kaminsky, Marie Christine; Lalami, Yassine; Henket, Monique; Keilholz, Ulrich; Knecht, Rainald
Informations sur la publication:	Cancer chemotherapy and pharmacology, 76, 1, page (13-20)
Statut de publication:	Publié, 2015-05
Sujet CREF:	Cancérologie
	Pharmacologie
	Toxicologie pharmaceutique
Mots-clés:	Anti-EGFR antibody
	EGFR resistance
	Head-neck cancer
	Phase 2a
	Sym004
	Treatment
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0344-5704
	info:doi/10.1007/s00280-015-2761-4
	info:scp/84934435726